Wednesday, January 03, 2018 10:15 PM ET
Charles River Labs (CRL) sees Significant Insider Sales
Two insiders — Robert J Bertolini, Director, and David Ross Smith, Officer — disposed of 11,840 shares of Charles River Labs having a market value of approximately $1,303,282, today, as reported in form 4 documents filed with the SEC. These are the first insider buy/sell trades in the past 90 days. Adding the most recent activity to this 90-day history indicates insider trades have averaged 5,920 shares per transaction.
Over the last 90 days, the number of insider buy/sell trades at Charles River Labs is greater than its 190-company peer group average. The Biotechnology & Medical Research peer group saw 153 buy/sell trades during this period for an average of 0.8 transactions per company. However, the number of shares traded per transaction by Charles River Labs insiders is lower than its peers. Within the peer group there were 28,270,107 shares purchased and 11,220,750 shares sold with company insiders having bought 148,255 shares on average over this time period.
In order to focus on significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated data used to create and write this story.
Today’s Insider Activity
* Robert J Bertolini, Director, sold 3,609 shares
* David Ross Smith, Officer, sold 8,231 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.